Cerutin

Leaflet attached to the packaging: patient information

CERUTIN, 100 mg + 25 mg, coated tablets

Ascorbic acid + Rutoside trihydrate

Read the leaflet carefully before taking the medicine, as it contains important information for the patient.

This medicine should always be taken exactly as described in this patient leaflet or as directed by a doctor or pharmacist.

• Keep this leaflet, you may need to read it again.
• If you need advice or additional information, consult a pharmacist.
• If you experience any side effects, including any possible side effects not listed in this leaflet, tell your doctor or pharmacist. See section 4.
• If there is no improvement or the patient feels worse after a few days, consult a doctor.

Table of contents of the leaflet

• 1. What is Cerutin and what is it used for
• 2. Important information before taking Cerutin
• 3. How to take Cerutin
• 4. Possible side effects
• 5. How to store Cerutin
• 6. Package contents and other information

1. What is Cerutin and what is it used for

Rutin and ascorbic acid (vitamin C) reduce the permeability and strengthen the blood vessel walls. Rutoside prolongs the action of vitamin C, delaying its oxidation. The medicine is indicated for use: in states of vitamin C and rutin deficiency - supporting the body's immunity; in sealing capillaries - preventing colds and alleviating flu symptoms.

2. Important information before taking Cerutin

When not to take Cerutin:

• if the patient is allergic to the active substances or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Before taking Cerutin, consult a doctor or pharmacist. The medicine should be used with caution in patients with hemoglobin synthesis disorders and hemochromatosis. It should not be taken simultaneously with sulfathiazole. Vitamin C in high doses may cause increased excretion of oxalic acid, gout, uric acid stones, cystinuria, hypokalemia, hypercalcemia.

Cerutin and other medicines

Tell your doctor or pharmacist about all medicines you are taking or have recently taken, as well as any medicines you plan to take. Increased action and toxicity of oral anticoagulant warfarin derivatives and sulfonamides (including the possibility of crystalluria). Vitamin C in doses greater than 1g per day may reduce the effectiveness of tricyclic antidepressants and aminoglycosides. Long-term use of rutin enhances the action of non-steroidal anti-inflammatory drugs. Vitamin C increases iron absorption from the gastrointestinal tract. High doses of acetylsalicylic acid reduce the concentration of ascorbic acid in platelets and plasma.

Pregnancy and breastfeeding

In pregnancy and breastfeeding, or if pregnancy is suspected, or if you plan to become pregnant, consult a doctor or pharmacist before taking this medicine. No studies have been conducted on the safety of the medicine in pregnant women.

Driving and operating machinery

The medicine does not impair psychophysical abilities, the ability to drive vehicles, and operate machinery.

Cerutin contains lactose

The medicine contains lactose (one coated tablet contains 1.90 mg of lactose). If you have previously been diagnosed with intolerance to some sugars, consult a doctor before taking the medicine.

3. How to take Cerutin

Orally. This medicine should always be taken as described in the patient leaflet or as directed by a doctor or pharmacist. In case of doubts, consult a doctor or pharmacist. Adults: Prophylactically: 1 to 2 tablets per day. In cases of vitamin C deficiency: 1 to 2 tablets 2 to 4 times a day. Children and adolescents: Prophylactically: up to 12 years: 1 tablet per day, from 12 to 18 years: 1 to 2 tablets per day. In cases of vitamin C deficiency: up to 12 years: 1 to 2 tablets 2 times a day, from 12 to 18 years: 1 to 2 tablets 2 to 4 times a day. The medicine should only be taken by children who can swallow the tablet.

Taking a higher dose of Cerutin than recommended

No cases of rutin and ascorbic acid overdose have been reported.

Missing a dose of Cerutin

Do not take a double dose to make up for a missed dose.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Reporting side effects

If you experience any side effects, including any possible side effects not listed in this leaflet, tell your doctor or pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products: Al. Jerozolimskie 181C, 02-222 Warsaw, Tel.: 22 49-21-301, Fax: 22 49-21-309, Website: https://smz.ezdrowie.gov.pl. Side effects can also be reported to the marketing authorization holder. By reporting side effects, you can help provide more information on the safety of the medicine.

5. How to store Cerutin

Store in a temperature below 25 °C. The medicine should be stored out of sight and reach of children. Do not use this medicine after the expiry date stated on the carton and blister after the words "EXP". The expiry date refers to the last day of the month stated. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Package contents and other information

What Cerutin contains

The active substances of the medicine are ascorbic acid and rutoside trihydrate. One tablet contains 100 mg of ascorbic acid and 25 mg of rutoside trihydrate. The other ingredients are: microcrystalline cellulose, corn starch, povidone, magnesium stearate. Coating: lactose monohydrate, hypromellose, titanium dioxide (E 171), macrogol 6000, yellow iron oxide (E 172).

What Cerutin looks like and what the package contains

Cerutin is a coated tablet. The tablets are yellow, round, and biconvex. The package contains 25, 100, 125, or 150 tablets in blisters.

Marketing authorization holder and manufacturer

Polfarmex S.A., ul. Józefów 9, 99-300 Kutno, Tel.: (24) 357 44 44, Fax: (24) 357 45 45, e-mail: [email protected]

Date of the last update of the leaflet